Clinical trial
Evaluation of the Artificial Intelligence/Machine Learning-Based Diagnostic Software as a Medical Device Using Forced Cough Vocalization Signal Data Signatures in the Diagnosis of COVID-19 Illness: A Prospective, Two-Arm Non-Inferiority Clinical Validation Trial of AudibleHealth Dx Software as a Medical Device (EUA-US)
NCT05364268 is registered in ClinicalTrials.gov with AudibleHealth AI, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Artificial Intelligence/Machine Learning-Based Diagnostic Software as a Medical Device Using Forced Cough Vocalization Signal Data Signatures in the Diagnosis of COVID-19 Illness: A Prospective, Two-Arm Non-Inferiority Clinical Validation Trial of AudibleHealth Dx Software as a Medical Device (EUA-US)
- Lead sponsor
- AudibleHealth AI, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 4, 2022
- Completion date
- June 1, 2022
- Enrollment
- 514 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
2019 novel coronavirus disease, 2019 novel coronavirus infection, 2019-ncov disease, coronavirus disease 2019, coronavirus disease-19, covid-19 pandemic, covid-19 virus disease, covid-19 virus infection, sars-cov-2 infection